Literature DB >> 23102616

The influence of gender on phenotype and disease progression in patients with Huntington's disease.

Daniel Zielonka1, Johan Marinus, Raymund A C Roos, Giuseppe De Michele, Stefano Di Donato, Hein Putter, Jerzy Marcinkowski, Ferdinando Squitieri, Anna Rita Bentivoglio, G Bernhard Landwehrmeyer.   

Abstract

INTRODUCTION: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. The aim of this study is to determine whether gender plays a role in the phenotypic expression and progression of HD.
METHODS: 1267 patients with HD (636 women) from the Registry project of the EHDN were included. A cross-sectional analysis (ANCOVA) controlling for differences in age at onset, disease burden, disease duration, smoking status, alcohol abuse, depression and the number of years of education, was performed to evaluate if there were differences between men and women in UHDRS motor, function and cognitive scores. Additionally, analyses on follow-up data using linear mixed models with the same covariates were performed to test for gender-related differences in progression.
RESULTS: Baseline features did not differ between genders, with the exception of a higher frequency of past and current depression among women, and a higher number of years of education as well as more frequent alcohol abuse and smoking among men. In the cross-sectional ANCOVA analyses of patients with a mid-age HD onset, women showed worse scores than men in the functional domain (TFC, P = 0.001; UHDRS functional, P = 0.033), UHDRS motor (P = 0.033). The longitudinal analyses showed a faster rate of progression in women in the functional assessment (P = 0.025), the motor assessment (P = 0.032) and the independence scale (P = 0.008).
CONCLUSIONS: These results suggest a complex gender effect on the phenotypical presentation and the rate of disease progression in HD, with slightly more severe phenotype and faster rate of progression in women in especially the motor and functional domains.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23102616     DOI: 10.1016/j.parkreldis.2012.09.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  38 in total

1.  Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.

Authors:  Yi Hong; Lauren J O'Donnell; Peter Savadjiev; Fan Zhang; Demian Wassermann; Ofer Pasternak; Hans Johnson; Jane Paulsen; Jean-Paul Vonsattel; Nikos Makris; Carl F Westin; Yogesh Rathi
Journal:  Hum Brain Mapp       Date:  2018-05-24       Impact factor: 5.038

2.  Huntington's disease in the United States: Variation by demographic and socioeconomic factors.

Authors:  Emilie Bruzelius; Joseph Scarpa; Yiyi Zhao; Sanjay Basu; James H Faghmous; Aaron Baum
Journal:  Mov Disord       Date:  2019-03-13       Impact factor: 10.338

3.  Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.

Authors:  Magali Cabanas; Cristiana Pistono; Laura Puygrenier; Divyangana Rakesh; Yannick Jeantet; Maurice Garret; Yoon H Cho
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 4.  Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.

Authors:  Nimra Hasnain; Taha Bin Arif; Roha Shafaut; Faiza Zakaria; Syeda Zainab Fatima; Ibtehaj Ul Haque
Journal:  Wien Med Wochenschr       Date:  2022-06-20

Review 5.  Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.

Authors:  Marta Daniela Costa; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.261

6.  A novel mistranslating tRNA model in Drosophila melanogaster has diverse, sexually dimorphic effects.

Authors:  Joshua R Isaacson; Matthew D Berg; Brendan Charles; Jessica Jagiello; Judit Villén; Christopher J Brandl; Amanda J Moehring
Journal:  G3 (Bethesda)       Date:  2022-05-06       Impact factor: 3.542

7.  Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease.

Authors:  Irene Ciancarelli; Daniela De Amicis; Caterina Di Massimo; Giorgio Sandrini; Caterina Pistarini; Antonio Carolei; Maria Giuliana Tozzi Ciancarelli
Journal:  Funct Neurol       Date:  2015 Jan-Mar

Review 8.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

9.  Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database.

Authors:  Samantha Hentosh; Liang Zhu; Jorge Patino; J Weldon Furr; Natalia P Rocha; Erin Furr Stimming
Journal:  Mov Disord Clin Pract       Date:  2021-03-08

Review 10.  Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.

Authors:  Emily Leung; Lili-Naz Hazrati
Journal:  Brain Commun       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.